Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Net Margin: 2020-2025

Historic Net Margin for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Sep 2025 value amounting to 2.18%.

  • Mirum Pharmaceuticals' Net Margin rose 1793.00% to 2.18% in Q3 2025 from the same period last year, while for Sep 2025 it was -8.78%, marking a year-over-year increase of 2373.00%. This contributed to the annual value of -26.10% for FY2024, which is 6158.00% up from last year.
  • Mirum Pharmaceuticals' Net Margin amounted to 2.18% in Q3 2025, which was up 147.62% from -4.59% recorded in Q2 2025.
  • Over the past 5 years, Mirum Pharmaceuticals' Net Margin peaked at 1,825.37% during Q4 2021, and registered a low of -942.16% during Q3 2021.
  • Moreover, its 3-year median value for Net Margin was -31.64% (2024), whereas its average is -46.99%.
  • Per our database at Business Quant, Mirum Pharmaceuticals' Net Margin plummeted by 931,195bps in 2021 and then surged by 75,203bps in 2022.
  • Quarterly analysis of 5 years shows Mirum Pharmaceuticals' Net Margin stood at 1,825.37% in 2021, then tumbled by 195,592bps to -130.55% in 2022, then soared by 7,928bps to -51.27% in 2023, then spiked by 2,734bps to -23.93% in 2024, then spiked by 1,793bps to 2.18% in 2025.
  • Its Net Margin was 2.18% in Q3 2025, compared to -4.59% in Q2 2025 and -13.15% in Q1 2025.